Schedule 13G ownership disclosure

Lexeo Therapeutics Inc

Common Stock · CUSIP: 52886X107

Event date: 2025-11-28

Filing-level shares
7,291,434
Percent of class
9.99%
  • JANUS HENDERSON GROUP PLC

    Shares: 7,291,434 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000338
Form type
SCHEDULE 13G/A
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Dec 08, 2025
Reporting period
Nov 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub